Petros Pharmaceuticals, Inc. (PTPI) Form 8-K — Jun 5, 2026
Petros Pharmaceuticals granted 7 million restricted shares to its Chairman, two directors, and its President/CCO on June 5, 2026. These awards were issued outside of the company’s existing Amended and Restated 2020 Omnibus Incentive Compensation Plan. The grants include 4.375 million shares to Chairman Joshua Silverman, 1.875 million to Director Bruce Bernstein, and 375,000 each to President Fady Boctor and Director Wayne Walker. Fifty percent of each award vested immediately, with the remainder vesting after six months contingent on continued service.
Key figures
- Shares Offered
- 7000000
- Shares to Boctor
- 375000
- Shares to Walker
- 375000
- Vesting schedule
- 50% on Grant Date, 50% on 6-month anniversary
- Shares to Bernstein
- 1875000
- Shares to Silverman
- 4375000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.